Persistence of <i>L. V. braziliensis</i> in the Nasal Mucosa of Treated Patients

Persistence of <i>L. V. braziliensis</i> in the Nasal Mucosa of Treated Patients

<b>Background/Objectives</b>: Cutaneous leishmaniasis is an infectious disease that most frequently affects neglected populations. Besides its incidence, a high disease burden is associated with the possibility of mucosal sequelae. Clinical follow-up of these patients is difficult due to...

Full description

Saved in:
Bibliographic Details
Main Authors: Jackeline Maria de Sousa Lima Lopes, Aline de Fatima Filha Santos, Renata Gabriella Ribeiro Ferreira, Thalion Gabriel Alves Moreira, Veronica Maria Gonçalves Furtado, Keven Styvenn Brito Santana, Thallyta Maria Vieira, Daniel Holanda Barroso, Sílvio Fernando Guimarães de Carvalho, Raimunda Nonata Ribeiro Sampaio
Format: Article
Language:English
Published: MDPI AG 2025-07-01
Series:Biomedicines
Subjects:
leishmaniasis
prognosis
real time polymerase chain reaction
cutaneous leishmaniasis
Online Access:https://www.mdpi.com/2227-9059/13/7/1634
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:<b>Background/Objectives</b>: Cutaneous leishmaniasis is an infectious disease that most frequently affects neglected populations. Besides its incidence, a high disease burden is associated with the possibility of mucosal sequelae. Clinical follow-up of these patients is difficult due to the limited access of the affected population to healthcare and the long lapse between the development of cutaneous and mucosal diseases. In this study, we evaluated the positivity of <i>L. V. braziliensis</i> DNA on the nasal mucosa of patients treated for leishmaniasis in an attempt to estimate the possible long-term risk of developing mucosal leishmaniasis and its association with important clinical characteristics. <b>Methods</b>: Samples were collected immediately after treatment completion using a nasal swab and specific DNA was amplified and detected using real-time PCR. Clinical and laboratorial data was systematically collected. <b>Results</b>: The positivity of <i>L. V. braziliensis</i> was 7% after treatment, and of this 60% had mucosal lesions before treatment, compared with only 13.4% in patients negative for <i>L. V. braziliensis</i> after treatment (<i>p</i> = 0.031). <b>Conclusions</b>: Molecular detection of <i>L. V. braziliensis</i> DNA on the nasal mucosa is a promising strategy to improve the follow-up and treatment of patients with American Tegumentary Leishmaniasis.
ISSN:2227-9059

Similar Items